BULLFROG AI HOLDINGS, INC. Basic Shares Outstanding (Weighted Average)
BULLFROG AI HOLDINGS, INC. (BFRG) reported Basic Shares Outstanding (Weighted Average) of 18.81 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- BULLFROG AI HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 18.81M shares, a 93.77% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 12.95M shares, a 33.63% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 11.56M shares, a 23.81% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 10.38M shares, a 27.75% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 10.34M shares, a 25.37% increase from fiscal 2024.
- BULLFROG AI HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 8.25M shares, a 36.29% increase from fiscal 2023.
- BULLFROG AI HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 6.05M shares, a 50.87% increase from fiscal 2022.
- BULLFROG AI HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 4.01M shares, a 2.59% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 18.81M shares 10-Q · filed 2026-08-14 | 15.89M shares 10-Q · filed 2026-08-14 | 14.44M shares derived: average of 3 quarters · filed 2026-08-14 | 13.43M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 12.95M shares 10-Q · filed 2026-05-14 | 12.26M shares derived: average of 2 quarters · filed 2026-05-14 | 11.63M shares derived: average of 3 quarters · filed 2026-05-14 | 11.15M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | 11.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 10.97M shares derived: average of 2 quarters · filed 2026-03-19 | 10.55M shares derived: average of 3 quarters · filed 2026-08-14 | 10.34M shares 10-K · filed 2026-03-19 |
| 2025-09-30 | 10.38M shares 10-Q · filed 2025-11-14 | 10.04M shares derived: average of 2 quarters · filed 2026-08-14 | 9.93M shares 10-Q · filed 2025-11-14 | 9.78M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | 9.71M shares 10-Q · filed 2026-08-14 | 9.70M shares 10-Q · filed 2026-08-14 | 9.58M shares derived: average of 3 quarters · filed 2026-08-14 | 9.22M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 9.69M shares 10-Q · filed 2026-05-14 | 9.52M shares derived: average of 2 quarters · filed 2026-05-14 | 9.05M shares derived: average of 3 quarters · filed 2026-05-14 | 8.82M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 9.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 8.73M shares derived: average of 2 quarters · filed 2026-03-19 | 8.53M shares derived: average of 3 quarters · filed 2026-03-19 | 8.25M shares 10-K · filed 2026-03-19 |
| 2024-09-30 | 8.12M shares 10-Q · filed 2025-11-14 | 8.12M shares derived: average of 2 quarters · filed 2025-11-14 | 7.88M shares 10-Q · filed 2025-11-14 | 7.71M shares derived: average of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | 8.12M shares 10-Q · filed 2025-08-13 | 7.76M shares 10-Q · filed 2025-08-13 | 7.57M shares derived: average of 3 quarters · filed 2025-08-13 | 7.20M shares derived: average of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | 7.39M shares 10-Q · filed 2025-05-13 | 7.29M shares derived: average of 2 quarters · filed 2025-05-13 | 6.89M shares derived: average of 3 quarters · filed 2025-05-13 | 6.68M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 7.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | 6.64M shares derived: average of 2 quarters · filed 2025-03-14 | 6.45M shares derived: average of 3 quarters · filed 2025-03-14 | 6.05M shares 10-K · filed 2025-03-14 |
| 2023-09-30 | 6.09M shares 10-Q · filed 2024-11-08 | 6.08M shares derived: average of 2 quarters · filed 2024-11-08 | 5.67M shares 10-Q · filed 2024-11-08 | 4.75M shares derived: average of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | 6.06M shares 10-Q · filed 2024-08-07 | 5.45M shares 10-Q · filed 2024-08-07 | 4.31M shares derived: average of 3 quarters · filed 2024-08-07 | 4.42M shares derived: average of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | 4.84M shares 10-Q · filed 2024-05-10 | 3.43M shares derived: average of 2 quarters · filed 2024-05-10 | 3.87M shares derived: average of 3 quarters · filed 2024-05-10 | 4.06M shares derived: average of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | 2.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 3.39M shares derived: average of 2 quarters · filed 2024-03-29 | 3.81M shares derived: average of 3 quarters · filed 2024-03-29 | 4.01M shares 10-K · filed 2024-03-29 |
| 2022-09-30 | 4.75M shares 10-Q · filed 2023-11-14 | 4.69M shares derived: average of 2 quarters · filed 2023-11-14 | 4.67M shares 10-Q · filed 2023-11-14 | |
| 2022-06-30 | 4.63M shares 10-Q · filed 2023-08-14 | 4.63M shares 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | 4.62M shares 10-Q · filed 2023-05-24 | |||
| 2021-12-31 | 4.12M shares 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |